At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 40 enrolled
Drug / intervention
Carboxymethylcellulose sodium, glycerin and polysorbate 80device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
In Brief
A Phase 3 clinical trial evaluating Carboxymethylcellulose sodium, glycerin and polysorbate 80 for Dry Eye Syndrome. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The main objectives of the investigation will be to assess the effect of the repeated usage of an investigational eye drop on the tear film characteristics of dry eye sufferers and demonstrate the benefit of this eye drops for dry eye sufferers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndrome
CountriesUnited Kingdom
CollaboratorsAllergan
Timeline
Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2011
First PostedApr 2011
Primary CompletionAug 2011
Study CompletionMay 2012
TodayJul 2026
First PostedApr 21, 2011
Enrollment StartMar 1, 2011
Primary CompletionAug 1, 2011
Study CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 15.2 years ago
Interventions
Carboxymethylcellulose sodium, glycerin and polysorbate 80device
1 drop in each eye three times a day for a period of 30 (± 4) days